Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Babcock & Wilcox in connection with the sale of its Italian and Swedish businesses
Mandate

Vinge advises Babcock & Wilcox in connection with the sale of its Italian and Swedish businesses

December 04, 2024

Vinge together with, among others, Dentons has advised Babcock & Wilcox Enterprises, Inc. (NYSE: BW), a US-based supplier of energy and environmental related products and services in conjunction with the sale of its Italy-based SPIG S.p.A. group of companies and its Swedish subsidiary Babcock & Wilcox Vølund AB (formerly Götaverken Miljö AB) to AUCTUS Capital Partners AG, a German and Italian private equity firm.

Vinge’s team primarily consisted of Kristian Ford, Niklas Törnell, Sofie Nordgren (FDI) and Lisa Bourghardt (IP).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026